Skip to content

Public FDA record

Z-0637-05: LIAISON 25 OH Vitamin D Assay, Manufacturer part # 310900, Lot # 114439E.

Recall record Z-0637-05 for Diasorin Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0637-05
Company in FDA record
Diasorin Inc.
FDA classification date
Mar 18, 2005
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 20, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Results of an internal inspection show Lot 114439E to have calibrator 1 and Calibrator 2 switched in their position in the integral. This results in an inability to calculate a curve, due to the reversal of calibrator values.

Source facts

Action
DiaSorin Customer Notification dated 02/14/05 was sent to customers instructing them to destroy all kits from the affected lot number. Customers were also asked to complete and return a form indicating how many kits were destroyed.
Initiated
2005-02-14
Root cause
Other
Terminated
2006-07-22
Distribution
MI, NJ, Germany, Spain and Belgium
Recall number
Z-0637-05
Recall status
Terminated
CDRH record ID
37284
FDA classified
2005-03-18
Recall event number
31167

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗